Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Pilotto

Showing results (1-10 of 228) with videos related to

Pageof 23
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 5, 2025
NSCLC Immunogenomics in People Living With HIV: Details Make the DifferenceSara Pilotto, Umberto Malapelle
Recenti Progressi in Medicina|December 15, 2025
[Sotorasib in non-small cell lung cancer KRAS G12C-mutated: from evidence to clinical practice.]Lorenzo Belluomini, Sara Pilotto
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 10, 2025
Further-Line Treatment With Amivantamab Plus Lazertinib in EGFR-Mutant NSCLC: New Answers to Old Questions?Sara Pilotto, Pawan Kumar Singh
Expert Opinion on Investigational Drugs|July 18, 2012
Sorafenib for lung cancer: is the "Battle" still open?Emilio Bria, Sara Pilotto, Giampaolo Tortora
Frontiers in Oncology|February 2, 2026
Editorial: Editor's challenge: Dr. Sara Pilotto - modulating tumor-host interplay through lifestyle in lung cancerAlice Avancini, Morten Quist, Sara Pilotto
Translational Lung Cancer Research|January 23, 2016
Platelets and their role in cancer evolution and immune systemNiki Karachaliou, Sara Pilotto, Emilio Bria, et al.
Journal of Thoracic Disease|December 10, 2017
Tracking occult pN2 disease after mediastinal dissection in early stage lung cancerCristiano Benato, Sara Pilotto, Maurizio Infante, et al.
JTO Clinical and Research Reports|March 18, 2024
Lung Cancer Screening: An Opportunity to Promote Physical Activity?Alice Avancini, Lorenzo Belluomini, Morten Quist, et al.
Seminars in Oncology|September 29, 2018
Avoiding chemotherapy for advanced nononcogene addicted NSCLC overexpressing PD-L1: Rule or option?Sara Pilotto, Luisa Carbognin, Antonio Rossi, et al.
Expert Opinion on Investigational Drugs|April 8, 2016
Platelet-derived growth factor receptor inhibitors for non-small cell lung cancer: is the odyssey over?Luisa Carbognin, Sara Pilotto, Umberto Peretti, et al.
Pageof 23

Showing results (1-10 of 228) with videos related to

Sort By:
Pageof 23
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 5, 2025
NSCLC Immunogenomics in People Living With HIV: Details Make the DifferenceSara Pilotto, Umberto Malapelle
Recenti Progressi in Medicina|December 15, 2025
[Sotorasib in non-small cell lung cancer KRAS G12C-mutated: from evidence to clinical practice.]Lorenzo Belluomini, Sara Pilotto
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 10, 2025
Further-Line Treatment With Amivantamab Plus Lazertinib in EGFR-Mutant NSCLC: New Answers to Old Questions?Sara Pilotto, Pawan Kumar Singh
Expert Opinion on Investigational Drugs|July 18, 2012
Sorafenib for lung cancer: is the "Battle" still open?Emilio Bria, Sara Pilotto, Giampaolo Tortora
Frontiers in Oncology|February 2, 2026
Editorial: Editor's challenge: Dr. Sara Pilotto - modulating tumor-host interplay through lifestyle in lung cancerAlice Avancini, Morten Quist, Sara Pilotto
Translational Lung Cancer Research|January 23, 2016
Platelets and their role in cancer evolution and immune systemNiki Karachaliou, Sara Pilotto, Emilio Bria, et al.
Journal of Thoracic Disease|December 10, 2017
Tracking occult pN2 disease after mediastinal dissection in early stage lung cancerCristiano Benato, Sara Pilotto, Maurizio Infante, et al.
JTO Clinical and Research Reports|March 18, 2024
Lung Cancer Screening: An Opportunity to Promote Physical Activity?Alice Avancini, Lorenzo Belluomini, Morten Quist, et al.
Seminars in Oncology|September 29, 2018
Avoiding chemotherapy for advanced nononcogene addicted NSCLC overexpressing PD-L1: Rule or option?Sara Pilotto, Luisa Carbognin, Antonio Rossi, et al.
Expert Opinion on Investigational Drugs|April 8, 2016
Platelet-derived growth factor receptor inhibitors for non-small cell lung cancer: is the odyssey over?Luisa Carbognin, Sara Pilotto, Umberto Peretti, et al.
Pageof 23